Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Aroa Biosurgery Ltd ( (AU:ARX) ) has shared an announcement.
Aroa Biosurgery Ltd has announced the quotation of 132,979 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code ARX. This move is part of the company’s strategy to enhance its market presence and provide additional liquidity for its stakeholders, potentially strengthening its position in the medical technology industry.
The most recent analyst rating on (AU:ARX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on Aroa Biosurgery Ltd stock, see the AU:ARX Stock Forecast page.
More about Aroa Biosurgery Ltd
Aroa Biosurgery Ltd operates in the medical technology industry, focusing on the development and commercialization of regenerative tissue products. The company’s primary products are designed for soft tissue repair and healing, targeting markets in healthcare and surgery.
Average Trading Volume: 383,439
Technical Sentiment Signal: Sell
Current Market Cap: A$172.5M
For an in-depth examination of ARX stock, go to TipRanks’ Overview page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue